
UK - Matrix realises 3.3x from full BBI exit
Matrix Private Equity Partners has realised over 3.3x its original investment of £2.3m through the sale of its shareholding in AIM-listed BBI Holdings Plc. Matrix originally invested in BBI, a healthcare business that focuses on diagnostics and diabetes, in 2000, before listing it on AIM in 2004. The final realisation opportunity arose through BBI’s recommended all cash or shares offer by Inverness Medical Innovations. Matrix funds have received £7.8 million proceeds over the seven year life of the investment, achieving an IRR of 31%.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater